Results 91 to 100 of about 229,521 (146)

Orbital Decompression in Graves’ Ophthalmopathy: Iferomedial Versus Balanced Medial Plus Lateral Wall Technique

, 2004
Orbital Decompression in Graves’ Ophthalmopathy: Iferomedial Versus Balanced Medial Plus Lateral Wall ...
SELLARI FRANCESCHINI, STEFANO, Mazzi B, Tanda ML, NARDI, MARCO, BERRETTINI, STEFANO, PINCHERA, ALDO, Santoro A, D'Anteo M, Mazzeo S, Bartalena L, MARCOCCI, CLAUDIO   +10 more
core  

Persistent hyperthyroidism and de novo Graves’ ophthalmopathy after total thyroidectomy

, 2017
We report a patient with Graves’ disease who remained persistently hyperthyroid after a total thyroidectomy and also developed de novo Graves’ ophthalmopathy 5  months after surgery.
Wann Jia Loh, Wei Lin Tay, Chiaw Ling Chng, Lianne Ai Ling Lee   +3 more
core   +1 more source

Pathogenesis of Graves’ Ophthalmopathy [PDF]

International Archives of Allergy and Immunology, 2009
C, Spitzweg, A E, Heufelder
openaire   +2 more sources

An Appraisal of the Preventive Effect of Statins on the Development of Graves’ Ophthalmopathy: A Hospital-Based Cohort Study

Ophthalmology and Therapy
Introduction Graves’ ophthalmopathy (GO) is an autoimmune inflammatory disorder observed in a substantial proportion of patients with Graves’ disease (GD), with debilitating symptoms of disfiguring, periorbital pain, dry eyes, diplopia, and even visual ...
Grace Chia-Yen Hsu, Shyang-Rong Shih, Fang-Yu Chang, Shu-Lang Liao, Yi-Hsuan Wei   +4 more
doaj   +1 more source

Prevalence of Graves ophthalmopathy among patients with thyroid disease

Philippine Journal of Ophthalmology, 2010
Objective: This study determined the prevalence of Graves ophthalmopathy among thyroid-disease patients at a tertiary government hospital. Methods: Patients with thyroid disease seen at a tertiary hospital from February to September 2007 were enrolled.
Erwin D. Palisoc, MD, Evelyn S. Morabe, MD, Paulo Ma. N. Pagkatipunan, MD   +2 more
doaj  

Treatment of ophthalmopathy in the course of Graves’ disease [PDF]

, 2019
: Introduction: Graves’ disease is an autoimmune disease in which the TSH receptor (TSHR) is an autoantigen. Its stimulation by antibodies inhibiting thyrotropin binding causes increased secretion of free thyroid hormones and consequently symptoms of ...
Woźniak, Magdalena, Rudzki, Grzegorz, Tywanek, Ewa, Świrska, Joanna, Zwolak, Agnieszka, Łuczyk, Robert Jan   +5 more
core  

Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy

Clinical Ophthalmology, 2012
Tom McCorquodale,1 Hooshang Lahooti,1 Bamini Gopinath,2 Jack R Wall11Department of Medicine, Nepean Clinical School, the University of Sydney, Penrith, NSW, Australia; 2Centre for Vision Research, the University of Sydney, Westmead Hospital, Westmead ...
McCorquodale T, Lahooti H, Gopinath B, Wall JR   +3 more
doaj  

Visual Field and Graves Ophthalmopathy

, 2015
Whether primary or secondary to thyroid disease, Graves\u27 ophthalmopathy is surprising by its evolution despite correct treatment. Transformation to acute mode may occur very quickly.
Sabine Defoort-Dhellemmes; Jean-Philippe Woillez; Virginie Rufin
core  

High-dose intravenous immunoglobulin treatment in Graves' ophthalmopathy.

, 1992
We have evaluated the efficacy of high-dose intravenous immunoglobulin treatment in Graves' ophthalmopathy, and have carried out a prospective randomized clinical trial, including a single-blind evaluation, whereby 14 patients were assigned to two ...
Alberti B, Canapicchi R, Baschieri L., ANTONELLI, ALESSANDRO, Lepri A, Saracino A, Laddaga M, Cartei F, Baldassare Alberti, Lidio Baschieri, Alessandro Antonelli, Raffaello Canapicchi, Antonio Lepri, Francesco Cartei, Michele Laddaga, Antonella Saracino   +15 more
core   +1 more source

Graves' ophthalmopathy

Swiss Medical Weekly, 2002
Swiss Medical Weekly
doaj   +1 more source